Keyword: Department of Defense
SPR Therapeutics received grants and a contract from the Army totaling $10 million to aid development of its nerve-stimulating pain device therapy.
SIGA Technologies tested its smallpox drug in 359 healthy volunteers to demonstrate safety and relied on animal data to show efficacy.
The seed round comes a year after Paradromics secured up to $18 million from the U.S. Department of Defense.
Controversial plans to allow the Pentagon to approve drugs and medical devices intended for use by soldiers have been set aside in the latest version of the defense bill.
FDA Commissioner Scott Gottlieb has hit back at plans that could see the Pentagon take control over the approval of some experimental drugs and devices for soldiers.
The U.S. DOD is putting up the money to give the army a better way of assessing moderate to severe traumatic brain injuries in combat situations.
The past week ushered in discoveries related to the genetics of immuno-oncology success, genes and heart failure, and treating Gulf War illness.
The Department of Defense awarded Johnson & Johnson a contract worth up to $260.5 million to supply it with orthopedic products.
Synchron raised $10 million for a trial of its implantable device designed to help paralyzed patients control robotic limbs and exoskeletons.
Berg is applying its technology to breast cancer samples gathered by a Department of Defense program.
